ClinicalTrials.govpublic full text
Sacituzumab Tirumotecan(Sac-TMT) and Brain Radotherapy for EGFR+ NSCLC With Brain Mets
non-small cell lung cancer, brain metastases from non-small cell lung cancer (nsclc), egfr mutation positive advanced non-small cell lung cancer, sacituzumab tirumotecan(sac-tmt/skb264)、brain radiotherapy、egfr-tki resistance、intracranial progression-free survival, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 875961
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.